Clinical Trial Update: Tolerance to NeuroEPO in Parkinson Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating tolerance to NeuroEPO in patients with Parkinson disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• NeuroEPO

Snippet

Sponsor: International Center for Neurological Restoration, Cuba | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: COMPLETED